Nektar Therapeutics NKTR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.9M+11.7% | -$36.08M— | -$35.52M+4.1% | -$41.59M+20.6% | -$50.88M-38.3% | ||
| $151K-64.6% | $190K-42.8% | $196K-80.3% | $214K-85.3% | $426K-73.5% | ||
| $3.36M-13.9% | $2.19M-54.3% | $3.07M-43.0% | $3.49M-35.7% | $3.9M-35.0% | ||
| -$44.3M+9.7% | -$64.96M-40.6% | -$48.76M-11.0% | -$45.74M-21.3% | -$49.05M-2.4% | ||
| $18K+800% | $18K-96.1% | $114K-82.9% | $37K-80.1% | $2K-98.7% | ||
| -$350.79M-903% | —— | -$94.87M-306% | $49.62M+192% | $43.69M+127% | ||
| $529.55M+7,564,886% | $38.67M+46,492% | $141.68M+1,089,723% | $211K+1,011% | $7K-100.0% | ||
| $134.46M+2,610% | -$25.92M-283% | -$1.96M-190% | —— | -$5.36M-140% | ||
| -$44.32M+9.7% | -$64.98M-39.3% | -$48.88M-9.6% | -$45.78M-20.8% | -$49.06M-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nektar Therapeutics generate?
- Nektar Therapeutics (NKTR) generated -$203.8M in operating cash flow over the trailing twelve months.
- What is Nektar Therapeutics's free cash flow?
- After $187.0K of capital expenditures, Nektar Therapeutics's free cash flow was -$203.9M over the trailing twelve months, down 14.4% year over year.
- Where does Nektar Therapeutics's cash flow data come from?
- Every line is extracted from Nektar Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
